KCG
IRD

Knight Capital Group’s Opus Genetics IRD Stock Holding History

Knight Capital Group’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$7K Buy
+32
New +$5.49K ﹤0.01% 3222

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BMC
Benin Management Corp Wilton, Connecticut $494M AUM 25.95% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Knight Capital Group's IRD Position: Q2 2013 in Review

Knight Capital Group opened a new position in Opus Genetics (IRD) in Q2 2013: 32 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #3222 among its holdings.

20 funds tracked by Wall St. Rank hold IRD as of Q2 2013.

  • Knight Capital Group held 32 shares of Opus Genetics worth $7K as of Q2 2013.
  • Opus Genetics was a new Knight Capital Group position in Q2 2013.
  • Opus Genetics made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3222 holding.
  • 20 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.